Promoter Hypermethylation in MLL-Rearranged Leukemias: Biology and Therapeutic Targeting |
The Johns Hopkins University School of Medicine / Eric Schafer |
Young Investigator Grants |
2010 |
Maryland |
The Role of Tumor Heterogeneity in Relapse of Pediatric Acute Myeloid Leukemia |
Children’s Hospital & Research Center at Oakland / Cheryl Peretz, MD |
Young Investigator Grants |
2019 |
California |
The Role of ARID1A in Neuroblastoma Pathogenesis |
Dana-Farber Cancer Institute / Hui Shi, PhD |
Young Investigator Grants |
2016 |
Massachusetts |
Identification of Novel Treatment Targets by Exploring the Interaction of Rhabdomyosarcoma-Associated Oncogenes with Cellular Context in a Mouse Model of Rhabdomyosarcoma |
Dana-Farber Cancer Institute / Simone Hettmer |
Young Investigator Grants |
2010 |
Massachusetts |
Bcl2-Family Inhibitors in Neuroblastoma: Mechanism of Action, Therapy Resistance, and Development of Biomarkers |
Children’s Hospital of Philadelphia / Claudia Zapata, MD |
Young Investigator Grants |
2019 |
Pennsylvania |
The Impact of Hypoxia on Epigenetic Changes in Neuroblastoma |
University of Chicago / Sakshi Uppal, PhD |
Young Investigator Grants |
2017 |
Illinois |
Altering master genetic regulators SNF5/INI1 and LIN28A to model and treat atypical teratoid/rhabdoid tumors |
The Johns Hopkins University School of Medicine / Eric Raabe |
Young Investigator Grants |
2011 |
Maryland |
Dissecting the Mechanism of Overgrowth and Tumorigenesis in Beckwith-Wiedemann Syndrome |
University of Pennsylvania / Jennifer Kalish, MD, PhD |
Young Investigator Grants |
2013 |
Pennsylvania |
Immunotherapeutic Targeting of Stem Cells in Pediatric Brain Tumors
|
Harbor - UCLA Medical Center / Joseph Lasky |
Young Investigator Grants |
2008 |
California |
Identifying Therapeutic Vulnerabilities in Pediatric AML through Investigation of the MECOM Transcriptional Network |
Boston Children’s Hospital / Richard Voit, MD/PhD |
Young Investigator Grants |
2023 |
Massachusetts |